Healthcare

Imricor Medical Systems Inc (ASX:IMR) shares climbed 5.54% to AUD 1.94 during the morning session on 8 April 2026, extending its strong 12-month performance with gains of 55.36%. Today’s upward move comes after the company announced it has submitted its NorthStar Mapping System to …

Neuren Pharmaceuticals Ltd (ASX:NEU) shares climbed 6.30% to AUD 13.08 during the morning session on 8 April 2026, extending its favourable momentum with gains of 40.74% over the past year.

Pro Medicus Limited (ASX:PME) shares surged by 7.98%, reaching AUD 131.72 during the morning trading session on 8 April 2026, this sharp upward movement comes as a welcome relief forshareholders, as the stock has faced a challenging environment recently, remaining down approximately 56.14% over …

HighlightsAustralia ranks among the global leaders in biotech research, supported by institutions like Walter and Eliza Hall Institute of Medical Research and Garvan Institute of Medical Research.The ASX biotech sector is largely driven by pre-revenue companies, where valuations depend on clinical trial success rather …

HighlightsCSL Limited anchors the sector with over US$15.5 billion in revenue and a diversified global portfolio across plasma, vaccines and nephrology.Telix Pharmaceuticals has delivered rapid commercial growth, with revenue up 56% driven by its radiopharmaceutical imaging product Illuccix.Mesoblast transitioned into a commercial-stage company following …

The small to mid-cap segment of theASXbiotech sector is where some of the most exciting growth stories and speculative opportunities reside. These companies typically havemarket capitalisationsranging from under one hundred million to approximately one billion dollars and are at various stages of clinical development. …

Partnershipsand licensing agreements are a critical component of theASXbiotech business model. Given the relatively small size of most Australian biotech companies and the enormous costs associated with late-stage clinical development and global commercialisation, partnerships with larger pharmaceutical companies provide a means of accessing thecapital, …